XVIVO - Updated outlook
Redeye updates our outlook after Q4 2022 XVIVO. The result confirms that the key value drivers are on fire and the outlook is positive. XVIVO beat both our and market expectations. We make a minor positive top line revision and increase our OPEX for 2023 and 2024 reflecting investments in ongoing and approaching launches. We increase our base case to SEK 385 (375) with a Bull of SEK 800 (785) and a Bear case of SEK 105 (105).
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/